Mainz Biomed N.V. (MYNZ)

Mainz Biomed Statistics

Total Valuation

Mainz Biomed has a market cap or net worth of $5.22 million. The enterprise value is $13.02 million.

Market Cap	5.22M
Enterprise Value	13.02M

Important Dates

The last earnings date was Monday, October 21, 2024, before market open.

Earnings Date	Oct 21, 2024
Ex-Dividend Date	n/a

Share Statistics

Mainz Biomed has 25.59 million shares outstanding. The number of shares has increased by 36.64% in one year.

Current Share Class	25.59M
Shares Outstanding	25.59M
Shares Change (YoY)	+36.64%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.67%
Owned by Institutions (%)	4.38%
Float	22.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.89
Forward PS	3.98
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.24

Current Ratio	0.24
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19.50

Financial Efficiency

Return on equity (ROE) is -4,333.72% and return on invested capital (ROIC) is -154.40%.

Return on Equity (ROE)	-4,333.72%
Return on Assets (ROA)	-99.24%
Return on Capital (ROIC)	-154.40%
Revenue Per Employee	$12,918
Profits Per Employee	-$316,998
Employee Count	71
Asset Turnover	0.07
Inventory Turnover	0.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.33% in the last 52 weeks. The beta is 0.08, so Mainz Biomed's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	-82.33%
50-Day Moving Average	0.26
200-Day Moving Average	0.57
Relative Strength Index (RSI)	39.56
Average Volume (20 Days)	5,359,274

Short Selling Information

The latest short interest is 1.52 million, so 5.93% of the outstanding shares have been sold short.

Short Interest	1.52M
Short Previous Month	1.70M
Short % of Shares Out	5.93%
Short % of Float	6.87%
Short Ratio (days to cover)	0.61

Income Statement

In the last 12 months, Mainz Biomed had revenue of $917,203 and -$22.51 million in losses. Loss per share was -$1.12.

Revenue	917,203
Gross Profit	540,958
Operating Income	-22.04M
Pretax Income	-26.30M
Net Income	-22.51M
EBITDA	-21.59M
EBIT	-22.04M
Loss Per Share	-$1.12

Balance Sheet

The company has $977,764 in cash and $8.27 million in debt, giving a net cash position of -$7.29 million or -$0.29 per share.

Cash & Cash Equivalents	977,764
Total Debt	8.27M
Net Cash	-7.29M
Net Cash Per Share	-$0.29
Equity (Book Value)	-4.14M
Book Value Per Share	-0.16
Working Capital	-7.62M

Cash Flow

In the last 12 months, operating cash flow was -$19.31 million and capital expenditures -$294,946, giving a free cash flow of -$19.60 million.

Operating Cash Flow	-19.31M
Capital Expenditures	-294,946
Free Cash Flow	-19.60M
FCF Per Share	-$0.77

Margins

Gross Margin	58.98%
Operating Margin	-2,402.78%
Pretax Margin	-2,453.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,662.00%

Dividends & Yields

Mainz Biomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.64%
Shareholder Yield	-36.64%
Earnings Yield	-392.69%
FCF Yield	-341.98%

Analyst Forecast

The average price target for Mainz Biomed is $3.00, which is 1,369.87% higher than the current price. The consensus rating is "Buy".

Price Target	$3.00
Price Target Difference	1,369.87%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	159.62%
EPS Growth Forecast (5Y)	-52.11%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mainz Biomed has an Altman Z-Score of -21.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.37
Piotroski F-Score	4